ProCE Banner Activity

The Why and Who: Overview of Newly Available and Emerging Biomarkers in Lung Cancer Therapy

Slideset Download
Download these slides to review expert insights from a medical oncologist on established and emerging biomarkers critical to optimal use of targeted therapy and immunotherapy in patients with NSCLC.

Released: November 12, 2020

Share

Faculty

Nathan Pennell

Nathan Pennell, MD, PhD

Professor
Director,
Cleveland Clinic Lung Cancer Medical Oncology Program
Department of Hematology and Medical Oncology
Cleveland Clinic Taussig Cancer Institute
Cleveland, Ohio

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Lilly

Faculty Disclosure

Primary Author

Nathan Pennell, MD, PhD

Professor
Director,
Cleveland Clinic Lung Cancer Medical Oncology Program
Department of Hematology and Medical Oncology
Cleveland Clinic Taussig Cancer Institute
Cleveland, Ohio